Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL): results in a homogeneous series from a single institution-Reference-Cited by-同舟云学术

Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL): results in a homogeneous series from a single institution

Published:2019-11-21 Issue:1 Volume:25 Page:69-75
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Salas María Queralt¹^ORCID,Climent Fina²,Tapia Gustavo³,DomingoDomènech Eva¹,Mercadal Santiago¹,Oliveira Ana Carla¹,Aguilera Carmen¹,Olga García⁴,Moreno Velázquez Miriam⁴,Andrade-Campos Marcio¹,Encuentra Maite¹,Fernández de Sevilla Alberto¹,Sureda Anna¹,Sancho Juan Manuel⁴,González-Barca Eva¹

Affiliation:

1. Department of Clinical Haematology, Institut Català Oncologia (ICO)-Hospitalet, IDIBELL, Barcelona, Spain;

2. Department of Pathology, University Hospital of Bellvitge, Barcelona, Spain;

3. Department of Pathology of Hospital Germans Trías i Pujol, Universitat Autònoma de Barcelona;

4. Department of Clinical Haematology of Institut Català Oncologia (ICO)-Hospital Germans Trias i Pujol, IJC, Badalona, Spain

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2019.1691656

Reference26 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2. The role of CD30 in the pathogenesis of haematopoietic malignancies

3. Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases

4. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

5. CD30 in Normal and Neoplastic Cells

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy;Cancer Letters;2024-02

2. CD30 expression in cutaneous B‐cell lymphomas;Journal of Cutaneous Pathology;2023-06-08

3. Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives;Annals of Hematology;2022-12-13

4. Genetic and phenotypic characterisation of HIV ‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications;Histopathology;2022-10-04

5. Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features;Leukemia & Lymphoma;2022-09-18